Re: CDIP/Guillium Barre -- IVIG Therapy vs Plasmapheresus
[ Follow Ups ] [ Post Followup ] [ Neurology and Neurosurgery Forum ] [ FAQ ]
Posted by CCF Neurology LG on March 01, 1998 at 03:15:16:
In Reply to: CDIP/Guillium Barre -- IVIG Therapy vs Plasmapheresus posted by MLR on February 28, 1998 at 15:28:57:
: My mother has CDIP (among several other auto immune disorders) - We are investigating intervention options. Can you refer us to a source or studies that compare and contrast the benefits of plasmapherisus (SP) vs. IVIG therapy? Also, can you tell us what the effects or contraindications of IVIG therapy are related to the kidneys. My mother only has one kidney. Additionally, my mother has had two boughts with septicimia from a central line -- what are the risk factors and the likelihood of a reoccurance of sepsis when receiving plasmapheresus? We have had a difficult time finding answers to these questions. Thank you for your assistance.
Several trials of IVIG have shown benefit in patients with CIDP. In one study, more that 50% of patients responded to treatment for weeks to months., after which the infusions must be repeated. This therapy tends to be very expensive and takes several hours for a transfusion. Rare instances of NEPHROTIC syndrome, low blood pressure, and meningitis have been reported but in general ther are no ill effects. Approximately 50% of the patients who undergo plasma exchange have reponded to therapy. In one study, plasma exchange administered two times a week for three weeks, had a beneficial effect on both neurologic disability and nerve conduction. However, the beneficial effects began to fade in 10-14 days. The respone to plasma exchange is comparable to that seen with IVIG, some patients responding better to certain treatments. Also there is always a chance of infection/sepsis with any intravenous line. Some references that may be helpful: 1. Plasma Exchange in CIDP, Hahn, Brain 119:p1055, 1996; 2. IVIG treatmetn in CIDP, Hahn, Brain 119:p1067, 1996; 3.Plasma Exchange in CIDP, Dyke, New England Journal of Medicine 314:461, 1986. I hope this helps. Good Luck.
Copyright 1994-2018MedHelp.All rights reserved. MedHelp is a division of Vitals Consumer Services, LLC.
The Content on this Site is presented in a summary fashion, and is intended to be used for educational and entertainment purposes only. It is not intended to be and should not be interpreted as medical advice or a diagnosis of any health or fitness problem, condition or disease; or a recommendation for a specific test, doctor, care provider, procedure, treatment plan, product, or course of action. MedHelp is not a medical or healthcare provider and your use of this Site does not create a doctor / patient relationship. We disclaim all responsibility for the professional qualifications and licensing of, and services provided by, any physician or other health providers posting on or otherwise referred to on this Site and/or any Third Party Site. Never disregard the medical advice of your physician or health professional, or delay in seeking such advice, because of something you read on this Site. We offer this Site AS IS and without any warranties. By using this Site you agree to the following Terms and Conditions. If you think you may have a medical emergency, call your physician or 911 immediately.